Zura Bio Limited's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Zura Bio Limited's ROI in the second quarter of 2026?
Zura Bio Limited recorded a cumulative net loss of $-112 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -70.4%.

Within the Healthcare sector 460 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2235 to 3844.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	2.03 %	-12.29 %	-12.15 %	13.43 %	48.52 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	197	217	102	118	139
Return On Investment (TTM)	-70.4 %	-70.33 %	-74.03 %	-45.18 %	-43.62 %
ZURA's Overall Ranking	# 3844	# 2235	# 3537	# 3246	# 2933
Seq. Investment Change TTM	10.07 %	12.83 %	-10.28 %	-8.43 %	-5.38 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-112	-101	-94	-64	-68

ZURA Company Profile >> Back to ZURA Roi Comparisons >> See Annual ZURA Return On Investment

Return On Investment ZURA's Ranking
Within:	No.
Industry	# 74
Sector	# 461
Overall	# 3844

Return On Investment Statistics
High	Average	Low
16.75 %	-45.61 %	-314.95 %
(Jun 30 2024)		(Mar 31 2021)

Financial Statements
Zura Bio Limited's II. Quarter Investments	$ 197 Millions	ZURA's Balance sheet
Zura Bio Limited's II. Quarter Income	$ -26 Millions	Quarterly ZURA's Income Statement
ZURA's Income by Division		See ZURA's Income by Division

ZURA Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	102	160	81	-22	140
Y / Y Investment Growth	-36.55 %	98.68 %	-	-	-
Net Income in Millions	-94	-45	-24	4	7
Y / Y Net Income Growth	-	-	-	-48.18 %	-
Annual Return On Investment	-93.05 %	-28.36 %	-29.98 %	-	4.88 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ZURA's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ZURA's Competitors
Subscribers only: Roi for Zura Bio Limited's Suppliers
Subscribers only: Return On Investment for ZURA's Customers

Other Ratios
ZURA's Roa	ZURA's Inventory Turnover Ratio	ZURA's Growth Rates	ZURA's Dividend Statistics
	ZURA's Profitability Ratios	ZURA's Asset Turnover Ratio	ZURA's Dividend Growth
ZURA's Roe	ZURA's Valuation Ratios	ZURA's Financial Strength Ratios	ZURA's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:40:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.